| Product NDC: | 68782-001 |
| Proprietary Name: | Macugen |
| Non Proprietary Name: | pegaptanib sodium |
| Active Ingredient(s): | 3.47 mg/mL & nbsp; pegaptanib sodium |
| Administration Route(s): | INTRAVITREAL |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 68782-001 |
| Labeler Name: | Eyetech Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021756 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20041217 |
| Package NDC: | 68782-001-02 |
| Package Description: | 1 SYRINGE in 1 CARTON (68782-001-02) > .09 mL in 1 SYRINGE |
| NDC Code | 68782-001-02 |
| Proprietary Name | Macugen |
| Package Description | 1 SYRINGE in 1 CARTON (68782-001-02) > .09 mL in 1 SYRINGE |
| Product NDC | 68782-001 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | pegaptanib sodium |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | INTRAVITREAL |
| Start Marketing Date | 20041217 |
| Marketing Category Name | NDA |
| Labeler Name | Eyetech Inc. |
| Substance Name | PEGAPTANIB SODIUM |
| Strength Number | 3.47 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Oligonucleotides [Chemical/Ingredient],Aptamers, Nucleotide [Chemical/Ingredient] |